insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.

Jared Kushner’s private equity firm, Affinity Partners, is reportedly pulling out as a partner of Paramount Skydance’s attempted hostile takeover of Warner Bros. Discovery, whose board unanimously ...

Journalist Jo Ling Kent joined CBS News in July 2023 as the senior business and technology correspondent for CBS News. Kent has more than 15 years of experience covering the intersection of technology ...

Affinity Partners, the firm founded by Donald Trump‘s son-in-law Jared Kushner, will no longer be a part of the group of investors backing Paramount‘s hostile takeover bid of Warner Bros. Discovery, a ...

Affinity Partners, Mr. Kushner’s private equity firm, played a small financial role in Paramount’s $108 billion offer, but it had attracted political attention to the deal. By Lauren Hirsch Jared ...

This expert-led webinar discusses how to break through common bottlenecks in TCR discovery with practical strategies that help teams move faster and smarter. T-cell receptor–T-cell engagers (TCR-TCEs) ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. This Account discusses recent progress and challenges in binding free energy ...